Steven Dibiase, MD
Radiation Oncology · Flushing, NYNPI 1750332292
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,297 of the $17,141 with a category attached, or 65.9%. Bayer accounts for 74.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $8,620 and has fallen 91.5% since, to $734 in 2025. Among radiation oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $323.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$13K
- Sirtex Medical Inc$2K
- Novocure Inc.$1K
- Siemens Medical Solutions USA, Inc.$863
- Trisalus Life Sciences, Inc.$222
- GT Medical Technologies, Inc$122
- plus $57 from 3 others
Across 15 payments — averaging $7713.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure Inc.$116K
What the payments were for
- Speaking & faculty fees$11,29766%
- Travel & lodging$2,58815%
- Food & beverage$3,25619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 17 | $12,840 |
| Sirtex Medical Inc | 16 | $1,936 |
| Novocure Inc. | 10 | $1,100 |
| Siemens Medical Solutions USA, Inc. | 5 | $863 |
| Trisalus Life Sciences, Inc. | 1 | $222 |
| GT Medical Technologies, Inc | 1 | $122 |
| Sanofi | 1 | $24 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xofigo$12,603
- SIR-Spheres Microspheres$1,668
- Varian Ethos Treatment Planning$579
- Optune$510
- Oncology$419
- TRINAV INFUSION SYSTEM$222
- Optune Gio$126
- GammaTile$122
- TrueBeam$109
How this compares
$17,141 in reported general payments places this provider in the 90th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Flushing
- Chung ChungSyracuse$3.1M
- Michael ZelefskyNew York$946K
- Jeffrey BogartSyracuse$772K
- Steven FinkelsteinSyracuse$578K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
- Dheerendra PrasadBuffalo$178K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.